Terumo Corp (4543) - Product Pipeline Analysis, 2018 Update
[Updated: 25-10-2018]

Published by Global Data on 25th October 2018 | Ref: 1085916 | This Report Is In Stock

$750 | Single User
$1500 | Site License
$2250 | Enterprise License
$750 | Single User
$1500 | Site License
$2250 | Enterprise License

Introduction

Summary

Terumo Corp (Terumo) is a medical technology company, which manufactures and sells a wide range of medical care products including hospital and medical products, and equipment. Its major product categories include vascular interventional products, cardiovascular surgical systems, artificial vascular grafts, blood transfusion systems, infusion systems, nutritious food, diabetes monitoring and treatment devices, cancer pain management systems, home oxygen therapy systems and consumer healthcare products. The company’s systems find application in and interventional therapies performed inside blood vessels and cardiac and vascular surgery. Terumo also operates blood centers for collecting blood and processing for addressing the transfusion requirement of patients. The company operates through its subsidiaries and associate companies in Japan, China, Europe, North America, South America, and Asia (excluding China and Japan). Terumo is headquartered in Tokyo, Japan.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company Terumo Corp

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

- The report provides detailed description of products in development, technical specification and functions

- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

- To formulate effective Research & Development strategies

- Develop market-entry and market expansion strategies

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc

- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Table of Contents

Table of Contents 2

List of Tables 5

List of Figures 7

Terumo Corp Company Overview 8

Terumo Corp Company Snapshot 8

Terumo Corp Pipeline Products and Ongoing Clinical Trials Overview 8

Terumo Corp – Pipeline Analysis Overview 11

Business Description 11

Terumo Corp - Key Facts 11

Terumo Corp - Major Products and Services 12

Terumo Corp Pipeline Products by Development Stage 14

Terumo Corp Ongoing Clinical Trials by Trial Status 21

Terumo Corp Pipeline Products Overview 24

Access Device For Infusion 24

Access Device For Infusion Product Overview 24

Advanced Coil 25

Advanced Coil Product Overview 25

Advanced WEB Aneurysm Embolization Device 26

Advanced WEB Aneurysm Embolization Device Product Overview 26

Advanced WEB Aneurysm Embolization Device Clinical Trial 27

Atherectomy Device 28

Atherectomy Device Product Overview 28

Cardiovascular Imaging System 29

Cardiovascular Imaging System Product Overview 29

CDI Inline Blood Gas Monitoring System 30

CDI Inline Blood Gas Monitoring System Product Overview 30

CMOS Image Glucose Sensor 31

CMOS Image Glucose Sensor Product Overview 31

Coated Stent 32

Coated Stent Product Overview 32

DuraHeart Destination Therapy Left Ventricular Assist System 33

DuraHeart Destination Therapy Left Ventricular Assist System Product Overview 33

ERIC Retrieval Device 34

ERIC Retrieval Device Product Overview 34

Flash PTCA 35

Flash PTCA Product Overview 35

FRED Flow-Diverting Stent 36

FRED Flow-Diverting Stent Product Overview 36

FRED Flow-Diverting Stent Clinical Trial 37

High Accuracy CGM 38

High Accuracy CGM Product Overview 38

IVUS 39

IVUS Product Overview 39

Large Volume Injector 40

Large Volume Injector Product Overview 40

Liver Cancer Ablation System 41

Liver Cancer Ablation System Product Overview 41

Mirasol Pathogen Reduction Technology System - Platelets 42

Mirasol Pathogen Reduction Technology System - Platelets Product Overview 42

Mirasol Pathogen Reduction Technology System - Platelets Clinical Trial 43

Mirasol Pathogen Reduction Technology System - Whole Blood 44

Mirasol Pathogen Reduction Technology System - Whole Blood Product Overview 44

Mirasol Pathogen Reduction Technology System - Whole Blood Clinical Trial 45

Next Generation Anaconda LP Stent Graft 46

Next Generation Anaconda LP Stent Graft Product Overview 46

Next Generation Drug Eluting Bioresorbable Scaffold 47

Next Generation Drug Eluting Bioresorbable Scaffold Product Overview 47

Next Generation Drug Eluting Stent - Complex Lesion 48

Next Generation Drug Eluting Stent - Complex Lesion Product Overview 48

Next Generation Oxygenator NX 49

Next Generation Oxygenator NX Product Overview 49

Next Generation SmartPump 50

Next Generation SmartPump Product Overview 50

Next Metallic Drug Eluting Stent 51

Next Metallic Drug Eluting Stent Product Overview 51

Ophthalmic Needle 52

Ophthalmic Needle Product Overview 52

Peripheral Therapeutic Device 53

Peripheral Therapeutic Device Product Overview 53

PLAJEX With FKB327 54

PLAJEX With FKB327 Product Overview 54

PLAJEX With Tapered Needle 55

PLAJEX With Tapered Needle Product Overview 55

Plastic Needle 56

Plastic Needle Product Overview 56

Relay NBS Plus 57

Relay NBS Plus Product Overview 57

Relay Thoracic Stent Graft With Plus Delivery System 58

Relay Thoracic Stent Graft With Plus Delivery System Product Overview 58

RelayBranch Thoracic Stent-Graft System 59

RelayBranch Thoracic Stent-Graft System Product Overview 59

RelayBranch Thoracic Stent-Graft System Clinical Trial 60

RelayPro Thoracic Stent-Graft System - Acute Complicated Type B Thoracic Aortic Dissection 61

RelayPro Thoracic Stent-Graft System - Acute Complicated Type B Thoracic Aortic Dissection Product Overview 61

RelayPro Thoracic Stent-Graft System - Acute Complicated Type B Thoracic Aortic Dissection Clinical Trial 62

RelayPro Thoracic Stent-Graft System - Blunt Traumatic Aortic Injury 63

RelayPro Thoracic Stent-Graft System - Blunt Traumatic Aortic Injury Product Overview 63

RelayPro Thoracic Stent-Graft System - Descending Thoracic Aortic Aneurysms 64

RelayPro Thoracic Stent-Graft System - Descending Thoracic Aortic Aneurysms Product Overview 64

RelayPro Thoracic Stent-Graft System - Descending Thoracic Aortic Aneurysms Clinical Trial 65

Renal Sympathetic Denervation System - TRI Technique 66

Renal Sympathetic Denervation System - TRI Technique Product Overview 66

Runner PTCA Balloon Catheter 67

Runner PTCA Balloon Catheter Product Overview 67

Runner Slim PTCA 68

Runner Slim PTCA Product Overview 68

Sofia Ex 69

Sofia Ex Product Overview 69

Therapeutic Apheresis System 70

Therapeutic Apheresis System Product Overview 70

Thoraflex Hybrid 71

Thoraflex Hybrid Product Overview 71

Thoraflex Hybrid Clinical Trial 72

TREO Abdominal Stent-Graft System 73

TREO Abdominal Stent-Graft System Product Overview 73

TREO Abdominal Stent-Graft System Clinical Trial 74

TREO Aorto-Uni-Iliac Abdominal Stent-Graft System 75

TREO Aorto-Uni-Iliac Abdominal Stent-Graft System Product Overview 75

TREO Aorto-Uni-Iliac Abdominal Stent-Graft System Clinical Trial 76

Treovance Abdominal Stent Graft With Navitel Delivery System 77

Treovance Abdominal Stent Graft With Navitel Delivery System Product Overview 77

Treovance Abdominal Stent Graft With Navitel Delivery System Clinical Trial 78

TRI PTA Balloon 79

TRI PTA Balloon Product Overview 79

TRI PTA Guiding Sheath 80

TRI PTA Guiding Sheath Product Overview 80

TRI Stent 81

TRI Stent Product Overview 81

Triplex Advanced Vascular Graft 82

Triplex Advanced Vascular Graft Product Overview 82

Ultimaster Tansei 83

Ultimaster Tansei Product Overview 83

WEB Aneurysm Embolization System 84

WEB Aneurysm Embolization System Product Overview 84

WEB Aneurysm Embolization System Clinical Trial 85

Terumo Corp - Key Competitors 87

Terumo Corp - Key Employees 88

Terumo Corp - Key Employee Biographies 91

Terumo Corp - Locations And Subsidiaries 92

Head Office 92

Other Locations & Subsidiaries 92

Joint Venture 95

Recent Developments 96

Terumo Corp, Recent Developments 96

Jul 09, 2018: Terumo to Increase Production Capacity for Alliance Business Pre-filled Syringes Capital Investment of 7 Billion Yen in Terumo Yamaguchi D&D Corporation 96

Jul 04, 2018: Terumo Announces Shipping Delays for Products from Ashitaka Factory 96

Jun 20, 2018: Terumo Acquires CE Marking for Kanshas Drug Coated Balloon Catheter for Lower Extremities 96

Jun 19, 2018: New Data Demonstrate Clinical Experience with Lifepearl Microspheres in over 300 Hepatocellular Carcinoma Patients 97

Jun 12, 2018: MicroVention Announces FDA Clearance For Thrombectomy Device 97

May 31, 2018: MicroVention Announces FDA Approval for Neuro Stent Device 98

May 24, 2018: Terumo to Launch the Ultimaster Tansei Drug Eluting Stent in Europe 98

May 17, 2018: Mirasol-Treated Platelets Show No Clinical Difference in Reducing Bleeding From Conventional Platelets in Plasma 99

May 11, 2018: Terumo Appoints its U.S. based Subsidiary's Associate as the Fifth Terumo Fellow 99

May 07, 2018: Terumo Recalls Sarns TCM and TCM II Cooling and Heating Systems and HX2 Temperature Management Systems Due to Revised Cleaning Instructions 100

Appendix 101

Methodology 101

About GlobalData 104

Contact Us 104

Disclaimer 104

Additional Details

Publisher

Global Data

Publisher Information

Reference

1085916 | GDME740PD

Number of Pages

103

Report Format

PDF

This report is published by Global Data

Download Free Report Summary PDF

Terumo Corp (4543) - Product Pipeline Analysis, 2018 Update [Updated: 25-10-2018] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.